跳至主要内容
临床试验/NCT04127656
NCT04127656终止不适用

Symptom Changes in Infants Fed an Amino Acid-based Formula

Abbott Nutrition6 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2019年12月16日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
26
试验地点
6
主要终点
Food Allergy Symptom Improvement

研究概览

简要总结

To observe the effects of an amino acid-based formula on symptoms associated with food allergies in infants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
— 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Subject is judged to be in good health as determined from subject's medical history
  • Subject is from a full-term birth with a gestational age of 37-42 weeks
  • Subject's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)
  • Subject has been documented to have CMPA and/or multiple food allergies, FPIES or gastrointestinal eosinophilic disorders.
  • Subject is experiencing persistent feeding intolerance symptoms including any of the following: regurgitation/vomiting associated with feeding (within 1 hour), constipation, diarrhoea, hematochezia (blood in the stool), crying, gassiness (wind), and/or skin rash/eczema.
  • Parent(s) confirm their intention to feed their infant study product during the study period.
  • Parent(s) confirm their intention not to administer vitamin or mineral supplements to their infant from enrolment through the duration of the study, unless instructed otherwise by their healthcare professional.
  • Infant using medications (OTC medications for gas [wind]), home remedies (such as juice for constipation), herbal preparations, prebiotics, probiotics or rehydration fluids that might affect Gl tolerance may not be enrolled unless the parent agrees to discontinue the use of these agents prior to enrolment or a healthcare professional recommends their continued use.
  • Subject's parent(s) has voluntarily signed and dated an ICF, approved by an IEC/IRB and provided applicable privacy regulation authorisation prior to any participation in the study.

排除标准

  • Subject is receiving steroids or antibiotics
  • Subject is tube-fed
  • Subject has received an amino acid-based formula
  • Subject has been diagnosed with: Short bowel syndrome, Inflammatory bowel disease, Pancreatic disease, Protein maldigestion (malnutrition), Mast cell disorder
  • Subject is participating in another study that has not been approved as a concomitant study by AN

结局指标

主要结局

Food Allergy Symptom Improvement

时间窗: Baseline to Day 28

Parent Completed Symptom Diary

次要结局

  • Time to Symptom Resolution or Reduction(Baseline to Day 28)
  • Study Formula Intake(Baseline to Day 28)
  • Change in Length(Baseline to Day 28)
  • Change in Weight(Baseline to Day 28)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验